Vaxinano was proud to participate in the latest edition of the Colloque I3M, where the team shared recent advances in vaccine research.
During the event, Christophe Barnier Quer and Aurane Lecouffe represented Vaxinano and presented the progress of the company’s latest activities. During the poster session, Romain Magnez showcased findings on the induction of a broad, multi-strain immune response generated by Vaxinano’s toxoplasmosis vaccine candidate.
This work reflects Vaxinano’s ongoing commitment to developing innovative vaccine strategies against complex infectious diseases and zoonotic threats.
The team would like to thank Didier Betbeder, Angelo Scuotto, and all colleagues involved for their continued support and contributions.
The Colloque I3M also provided a valuable opportunity to exchange with researchers from diverse backgrounds and foster new collaborations to advance vaccine innovation.
#Vaxinano #Toxoplasmosis #Vaccine #Zoonosis #Inserm #I3M